Navigation path

Additional tools

  • Print version
  • Decrease text
  • Increase text
  • Choose high contrast version
  • Choose standard colour version




Profile of registrant

Genzyme Corporation

Identification number in the register: 2946627525-90
Registration date: 17/10/08 14:57:50

The information on this organisation was last modified on 02/10/14 15:23:45
The date of the last annual update was 02/10/14 15:23:45


Registrant : Organisation or self-employed individual

Name/company name: Genzyme Corporation
Acronym:
Legal status: Corporation
Website address: http://www.genzyme.com

Sections

Section: II - In-house lobbyists and trade/professional associations
and more precisely: Companies & groups

Person with legal responsibility

Surname, Name: Mr  David Meeker
Position: CEO

Permanent person in charge of EU relations

Surname, Name: Ms  Vinciane Pirard
Position: Director Public Affairs

Contact details:

Contact details of organisation's head office: 500 Kendall Street 
Cambridge MA 02142
UNITED STATES
Telephone number: (+1) 617 252 7500
Fax number: (+) 
Other contact information: Gooimeer 10
1411DD Naarden
The Netherlands

or

Rue de la Science 14
1000 Bruxelles
Belgium

Goals / remit

Goals / remit of the organisation: Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals through world-class research and with the compassion and commitment of our employees. With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve. That goal guides and inspires us every day. Genzyme’s portfolio of transformative therapies, which are marketed in countries around the world, represents groundbreaking and life-saving advances in medicine. As a Sanofi company, Genzyme benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.
The organisation's fields of interests are:
  • global

Number of persons engaged in activities falling under the scope of the Transparency Register

Number of persons: 3
Complementary information:

Persons accredited for access to European Parliament premises

No accredited persons

Activities

Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:


To facilitate access to treatments for high, unmet medical need especially rare genetic diseases and multiple sclerosis.
To support all aspects supporting Europe’s Innovation and Research & Development activities in healthcare.

Fields of interest for e-mail alerts on consultations and roadmaps;

Fields declared by the organisation:
  • Consumer Affairs
  • Economic and Financial Affairs
  • Enterprise
  • Public Health
  • Research and Technology

Networking

Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.




Member of BIO (US), PhARMA (US), EFPIA (EU), EBE (EU) & EuropaBio (EU)

Financial data

Financial year: 01/2013 - 12/2013
Estimated costs to the organisation directly related to representing interests to EU institutions in that year: 150000  € - 200000  €
Amount and source of funding received from the EU institutions in financial year n-1 of registration
Procurement: 0 €
Grants: 0 €
Other (financial) information provided by the organisation:


Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.